MORRIA Trademark

Trademark Overview


On Monday, March 8, 2010, a trademark application was filed for MORRIA with the United States Patent and Trademark Office. The USPTO has given the MORRIA trademark a serial number of 77953759. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 14, 2013. This trademark is owned by Morria Biopharmaceuticals Plc. The MORRIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products and preparations for treating disease, namely, obstructive respiratory disease, asthma, inflammatory and anti-viral diseases, colitis, Crohn's disease, central nervous system insult, multiple sclerosis, contact dermatitis, psoriasis, cardiovascular disease, invasive cellular proliferative disorders, allergic rhinitis, cystic fibrosis, inflammatory disease of the skin, ophthalmologic diseases, hemolytic syndromes, sepsis, acute respiratory distress syndrome, tissue transplant rejection syndromes, autoimmune disease, viral infection, and hypersensitivity conjunctivitis; pharmaceuticals for use as a coating for cardiovascular stents and other stents; coating treatments, namely, pharmaceutical preparations used to coat devices for the prevention of inflammatory reactions as a result of invasive procedures; anti-oxidants supplements; pharmaceutical preparations, namely, anti-inflammatories and analgesics
morria

General Information


Serial Number77953759
Word MarkMORRIA
Filing DateMonday, March 8, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 14, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 19, 2011

Trademark Statements


Goods and ServicesPharmaceutical products and preparations for treating disease, namely, obstructive respiratory disease, asthma, inflammatory and anti-viral diseases, colitis, Crohn's disease, central nervous system insult, multiple sclerosis, contact dermatitis, psoriasis, cardiovascular disease, invasive cellular proliferative disorders, allergic rhinitis, cystic fibrosis, inflammatory disease of the skin, ophthalmologic diseases, hemolytic syndromes, sepsis, acute respiratory distress syndrome, tissue transplant rejection syndromes, autoimmune disease, viral infection, and hypersensitivity conjunctivitis; pharmaceuticals for use as a coating for cardiovascular stents and other stents; coating treatments, namely, pharmaceutical preparations used to coat devices for the prevention of inflammatory reactions as a result of invasive procedures; anti-oxidants supplements; pharmaceutical preparations, namely, anti-inflammatories and analgesics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 12, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMorria Biopharmaceuticals Plc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLondon W1K5JH
GB

Party NameMorria Biopharmaceuticals Plc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLondon W1K5JH
GB

Trademark Events


Event DateEvent Description
Tuesday, October 15, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 14, 2013ABANDONMENT - NO USE STATEMENT FILED
Friday, March 29, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 28, 2013EXTENSION 3 GRANTED
Monday, March 11, 2013EXTENSION 3 FILED
Tuesday, March 26, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 11, 2013TEAS EXTENSION RECEIVED
Tuesday, September 11, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, September 9, 2012EXTENSION 2 GRANTED
Thursday, September 6, 2012EXTENSION 2 FILED
Sunday, September 9, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 6, 2012TEAS EXTENSION RECEIVED
Thursday, March 15, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 13, 2012EXTENSION 1 GRANTED
Tuesday, March 13, 2012EXTENSION 1 FILED
Tuesday, March 13, 2012TEAS EXTENSION RECEIVED
Tuesday, March 13, 2012TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 13, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 19, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 19, 2011PUBLISHED FOR OPPOSITION
Tuesday, June 14, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, June 13, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 13, 2011EXAMINER'S AMENDMENT ENTERED
Monday, June 13, 2011NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, June 13, 2011EXAMINERS AMENDMENT E-MAILED
Monday, June 13, 2011EXAMINERS AMENDMENT -WRITTEN
Saturday, January 29, 2011NOTIFICATION OF FINAL REFUSAL EMAILED
Saturday, January 29, 2011FINAL REFUSAL E-MAILED
Saturday, January 29, 2011FINAL REFUSAL WRITTEN
Friday, January 7, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 7, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 7, 2011ASSIGNED TO LIE
Thursday, December 9, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 9, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 9, 2010NON-FINAL ACTION E-MAILED
Wednesday, June 9, 2010NON-FINAL ACTION WRITTEN
Wednesday, June 9, 2010ASSIGNED TO EXAMINER
Friday, March 12, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, March 11, 2010NEW APPLICATION ENTERED IN TRAM